NovaBay Pharma (NBY) Misses Q2 EPS by 6c

August 11, 2016 5:09 PM EDT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

NovaBay Pharma (NYSE: NBY) reported Q2 EPS of ($0.36), $0.06 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $2.7 million versus the consensus estimate of $1.76 million.

For earnings history and earnings-related data on NovaBay Pharma (NBY) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment